Clinical Trial Update: Bipolar Androgen-based Therapy for Prostate Cancer (BAT) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Bipolar Androgen-based Therapy (BAT) for recurrent prostate cancer has completed and posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Bipolar Androgen-based Therapy (BAT)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-12-05